A recent interview with Glaxo's Andrew Witty saw BBC journalist, Evan Davis, more or less told how to phrase questions. Davis had broached the subject of Glaxo's murky past - Witty, using the art of deflection, told Davis, "I think the bigger question is, where do you want to go forward?"
So, how do you polish a turd?
Well, you talk about what you have in the pipeline, (excuse the pun) thus eliminating tricky questions about the following...
6/4/2015 - India Meningitis Vaccine Market Collusion - GlaxoSmithKline, Sanofi-Aventis - $9,442,587
9/15/2014 - Clean Air Act Violation at Hamilton, MT Facility - GlaxoSmithKline - $172,900
8/11/2014 - Hazardous Waste Violations in King of Prussia - GlaxoSmithKline - $317,550
6/4/2014 - Multistate Illegal Marketing Settlement - GlaxoSmithKline - $105,000,000
5/13/2014 - China Bribery and Fraud - GlaxoSmithKline - $487,000,000
3/25/2014 - Mylan v. GlaxoSmithKline (Breach of Generic Paxil Agreements) - GlaxoSmithKline - $106,700,000
3/18/2014 - Contaminated Drug Ingredients at Ireland Plant - GlaxoSmithKline - FDA Warning Letter
12/17/2013 - Maryland Diabetes Drug Improper Marketing Lawsuit - GlaxoSmithKline - $15,000,000
7/24/2013 - Multistate Avandia Settlement (July 2013) - GlaxoSmithKline - $184,000,000
6/14/2013 - Cappellino v. GlaxoSmithKline (Gender Discrimination) - GlaxoSmithKline - Complaint
4/19/2013 - OFT Paroxetine Antitrust Investigation - GlaxoSmithKline - U.K. Office of Fair Trading Press Release
2/5/2013 - Louisiana Off-Label Marketing Lawsuit - GlaxoSmithKline - $45,000,000
11/15/2012 - Multistate Avandia Settlement (November 2012) - GlaxoSmithKline - $90,000,000
11/15/2012 - Flonase Antitrust Litigation - GlaxoSmithKline - $150,000,000
7/9/2012 - Dolin v. GlaxoSmithKline (Paxil Wrongful Death) - GlaxoSmithKline - Complaint
4/17/2012 - Idaho Average Wholesale Price Lawsuit - GlaxoSmithKline - $2,600,000
2/7/2012 - Defrauding Louisiana’s Medicaid Program - GlaxoSmithKline - $10,000,000
1/11/2012 - Argentina Vaccine Trials Fine - GlaxoSmithKline - $93,000
11/3/2011 - Criminal and Civil Investigations Settlement - GlaxoSmithKline - $3,000,000,000
10/27/2011 - South Korea Antitrust Fine - GlaxoSmithKline - $2,651,737
10/7/2011 - Current Good Manufacturing Practice Violations at Worthing, UK Facility - GlaxoSmithKline - FDA Warning Letter
6/27/2011 - Nigeria Trademark Infringement - GlaxoSmithKline - $7,873,706
6/23/2011 - Puerto Rico Drug Manufacturing Facility Settlement - GlaxoSmithKline - $40,750,000
5/17/2011 - South Carolina Attorney General Avandia Lawsuit - GlaxoSmithKline - Complaint
2/15/2011 - Louisiana Attorney General Avandia Lawsuit - GlaxoSmithKline - Complaint
11/17/2010 - Humana v. GlaxoSmithKline (Reimbursement for Avandia-Related Injuries) - GlaxoSmithKline - Complaint
11/9/2010 - Utah Attorney General Avandia Lawsuit - GlaxoSmithKline - $8,500,000
10/26/2010 - Puerto Rico Drug Manufacturing Facility Settlement - GlaxoSmithKline - $750,000,000
10/6/2010 - Hawaii Average Wholesale Price Litigation - GlaxoSmithKline - $10,000,000
8/30/2010 - Kentucky Kytril and Zofran Average Wholesale Price Lawsuit - GlaxoSmithKline - $3,750,000
7/12/2010 - U.S. Senate Investigation of Avandia - GlaxoSmithKline - Senate Finance Committee Letter to FDA
6/23/2010 - Paxil Birth Defect Litigation - GlaxoSmithKline - Confidential settlement with 190 families
4/19/2010 - FDA Review of Altabax Promotional Material - GlaxoSmithKline - FDA Warning Letter
10/13/2009 - Kilker v. SmithKline Beecham (Paxil Birth Defects) - GlaxoSmithKline - $2,500,000
10/1/2009 - Denture Cream Product Liability Litigation - GlaxoSmithKline - Complaint
12/23/2008 - Santa Clara County Drug Pricing Lawsuit - GlaxoSmithKline, Wyeth - Complaint
9/30/2008 - Paxil Class Action (National) - GlaxoSmithKline - $40,000,000
7/26/2008 - Medicines Australia Code of Conduct Violations - GlaxoSmithKline - $310,000
7/21/2008 - Relenza Litigation Settlement - GlaxoSmithKline - $19,500,000
5/19/2008 - Release of TCE in Scottsdale, AZ - GlaxoSmithKline - EPA Press Release
5/2/2008 - Wellbutrin Direct Purchaser Antitrust Litigation - GlaxoSmithKline - $49,500,000
2/27/2008 - Bartram v. GlaxoSmithKline (Paxil Birth Defects) - GlaxoSmithKline - Complaint
12/17/2007 - Avandia Marketing, Sales Practices and Products Liability Litigation - GlaxoSmithKline - $770,000,000
10/6/2006 - Paxil Class Action Litigation (Madison County, IL) GlaxoSmithKline - $63,833,148
9/11/2006 - Under-reporting Profits - GlaxoSmithKline - $3,400,000,000
7/10/2006 - Cunningham v. GSK (Paxil Wrongful Death) - GlaxoSmithKline - Complaint
3/28/2006 - Paxil Multistate Litigation - NY Attorney General Settlement - GlaxoSmithKline - $14,000,000
9/20/2005 - Zofran and Kytril False Claims Act Violations - GlaxoSmithKline - $150,000,000
4/1/2005 - Relafen Multistate Litigation - NY Attorney General Settlement - GlaxoSmithKline - $10,000,000
11/24/2004 - Relafen Consumer Litigation - GlaxoSmithKline - $75,000,000
8/26/2004 - Paxil New York Litigation - GlaxoSmithKline - $2,500,000
7/8/2004 - Augmentin Antitrust Litigation - GlaxoSmithKline - $92,000,000
2/6/2004 - Relafen Antitrust Litigation - GlaxoSmithKline - $175,000,000
4/16/2003 - Overcharging Medicaid - GlaxoSmithKline - $87,600,000
9/6/2002 - Average Wholesale Price (AWP) Drug Litigation - GlaxoSmithKline - $70,000,000
6/6/2001 - Tobin v. SmithKline Beecham (Paxil Wrongful Death) - GlaxoSmithKline - $6,400,000
**TOTAL - $10,057,614,485 (That's 10 billion, folks!)
**Federal Contractor Misconduct Database
There are many more missing from the Federal Contractor Misconduct Database, most notably the settlement (resolution) GSK made with over 3,000 Paxil plaintiffs who alleged the drug had caused them addiction problems, Also missing is the individual payment made to Pennsylvania mother Joanne Thomas who settled with GSK after losing her original case against them, see here and here.
The UK Seroxat Group Action is also missing from the list. The claim alleges that UK consumers become dependent upon the antidepressant, Seroxat. (Paxil)
Then, of course, we have the on-gong investigations of bribery and corruption in the following countries, United Kingdom, Iraq, Poland, Bahrain, Jordan, Kuwait, Lebanon, Syria, Oman, Qatar, and United Arab Emirates.
The mission of GSK, according to their website, is to improve the quality of human life by enabling people to do more, feel better and live longer.
(Insert laughter here)
Bob Fiddaman
No comments: